Adjunct Dexmedetomidine (Precedex) Therapy Impact on Sedative and Analgesic Requirement.

Trial Profile

Adjunct Dexmedetomidine (Precedex) Therapy Impact on Sedative and Analgesic Requirement.

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 05 Oct 2011

At a glance

  • Drugs Dexmedetomidine (Primary) ; Fentanyl; Propofol
  • Indications Pain; Sedation
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jul 2011 Planned end date changed from 1 Jul 2009 to 1 Mar 2009 as reported by ClinicalTrials.gov.
    • 07 Jul 2011 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 27 Feb 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top